3 Things cover image

The new Waqf bill, Manish Sisoda's bail, and waiver for clinical trials

3 Things

00:00

Expedited Drug Approvals in India

This chapter examines a new order from India's drug regulator allowing certain international drugs to enter the Indian market without local clinical trials. It discusses the implications for drug safety and efficacy, the categories of drugs affected, and the factors influencing their success in diverse populations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app